2026年 议程

Cambridge VIP主办第三届

Bio-IT World Venture, Innovation & Partnering

Connect Capital and Science to Shape the Future
连结资本与科学，塑造未来

2026年5月19日

 

第三届 Bio-IT World Venture, Innovation & Partnering Conference（2026年5月19日）将作为第25届 Bio-IT World Conference & Expo的一环，提供推动下一代生物技术和精准医疗的投资者、企业领导者和企业家提供一个高阶平台。这场小规模活动将邀集来自创投、私募股权、企业创投部门、成长阶段公司和制药公司的最高管理阶层领导者齐聚于此。2026 年议程节目的重点在人工智慧驱动的药物发现、平台与产品投资模式、不断进化的并购和合作策略、IPO和私募流动性途径，以及影响资本配置的监管变化。各节目单元旨在为投资者提供有关市场动态、风险调整回报和可扩展创新策略的清晰见解。透过坦诚的讨论、炉边谈话和精心策划的小组讨论，与会者将可探索资本如何分配、创新管道的发展方向以及如何识别长期赢家。除了以投资者为中心的意见交流之外，藉由超过 150 场展览、11 个科学轨道以及 30 多个国家的全球合作伙伴，以拓宽他们的市场视野。

Preliminary Agenda

Chairperson's Remarks

Morgan Cheatham, MD, Partner, Head of Healthcare & Life Sciences, Breyer Capital

Rana Lonnen, General Partner, Science Capital

William T. Mayo, Senior Vice President, Research Technology, BMS

Leadership at the Cutting Edge: Innovation, Strategy & Biotech’s Next Frontier

Michael Nally, CEO, Generate Biomedicines, and CEO/Partner, Flagship Pioneering, Flagship Pioneering

From Start-Up CEO to Global AI Leader: What the Future of Drug Discovery Tells Us About Tomorrow’s Best Investments

John Chan, Global Head Digital Informatics & AI, Novartis Pharmaceuticals

Interviewed By:

Rana Lonnen, General Partner, Science Capital

PANEL DISCUSSION:

Driving Innovation Together: The New Rules of VC, Pharma & Industry Leader Collaboration

PANEL MODERATOR:

William T. Mayo, Senior Vice President, Research Technology, BMS

PANELISTS:

Sandeep Burugupalli, Head, Data Science & Biopharmaceuticals R&D, AstraZeneca

PANEL DISCUSSION:

Innovation at the Helm: CEO Journeys through Company Building & Market Breakthroughs

PANEL MODERATOR:

Joanne L. Viney, PhD, Co-Founder & President & CEO, Seismic Therapeutic

PANELISTS:

Catherine Sabatos-Peyton, PhD, CEO, Larkspur Biosciences, Inc.

Rachel Humphrey, MD, President and Founding CEO, Normunity

Adam Townsend, CEO, Merida Biosciences

PANEL DISCUSSION:

Funding the Modern Pipeline: Capital Strategy across Biology, Technology, and Informatics

PANEL MODERATOR:

Rebecca Stevenson, Head, Healthcare Investment Banking, Americas, HSBC

PANELISTS:

Luba Greenwood, CEO, Gallop Oncology

Sophie Jones, CFO, Seismic Therapeutic

Stephanie Oestreich, Managing Director, Myeloma Investment Fund of the MMRF

PANEL DISCUSSION:

Discovery to Delivery: Innovation in Life Sciences and the Models that Scale It

PANEL MODERATOR:

Morgan Cheatham, MD, Partner, Head of Healthcare & Life Sciences, Breyer Capital

PANELISTS:

Cris De Luca, Partner, Sanofi Ventures

Bill Fitzgerald, Head, Biotechnology Markets Americas, Google

PANEL DISCUSSION:

The Future of Lab Funding: Building Stronger Pathways between Academia, Capital, and Spinouts

PANEL MODERATOR:

Michael Langer, Co-Founder and Managing Partner, T.Rx Capital


* 活动内容有可能不事先告知作更动及调整。